iatroX logo
brainstormaskiatroXuk q-bankus q-bankknowledge centreblog
Knowledge Centre / Ehlers-Danlos Syndromes (EDS)

Ehlers-Danlos Syndromes (EDS)

Overview and management of EDS.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
RheumatologyGenetics

Clinical Guidelines

NHS: Ehlers-Danlos syndromes
National
The Ehlers Danlos Society: Management and Care Guidelines
National
The Ehlers-Danlos Support UK
National
Diagnosis and treatment of the Ehlers-Danlos syndromes in China: a consensus statement
Local
NZ EDS Guideline V1 2019
Local
The 2017 international classification of the Ehlers-Danlos syndromes
Local

Recent iatroX Q&As

  • What are the key clinical features to consider when diagnosing Ehlers-Danlos Syndromes in a primary care setting?Updated: 8/16/2025
  • Which investigations are recommended to confirm a diagnosis of Ehlers-Danlos Syndromes?Updated: 8/16/2025
  • What are the current management strategies for patients with Ehlers-Danlos Syndromes experiencing joint pain?Updated: 8/16/2025
  • When should I refer a patient with suspected Ehlers-Danlos Syndromes to a specialist for further evaluation?Updated: 8/16/2025
  • What lifestyle modifications can I recommend to patients with Ehlers-Danlos Syndromes to help manage their symptoms?Updated: 8/16/2025
askiatroX
privacytermshow it workscpdinsightsfaqabout
UKCA Mark

iatroX is a UKCA-marked, MHRA-registered medical device.

Download on the App StoreGet it on Google Play